EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023

Rhea-AI Summary

EDAP TMS SA to release Q3 2023 financial results on November 9th and host conference call and webcast

Positive

• EDAP TMS SA will release its financial results for Q3 2023 on November 9th, 2023. They are the global leader in robotic energy-based therapies.

Negative

• None.

Company to host conference call and webcast on Thursday, November 9^th at 8:30am EDT

LYON, France, October 26, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the third quarter ended September 30^th, 2023, before the markets open on Thursday, November 9^th, 2023.

An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, François Dietsch, Chief Financial Officer and Ken Mobeck, Chief Financial Officer of the U.S. subsidiary. The call will be held at 8:30am EDT on Thursday, November 9^th, 2023. Please refer to the information below for conference call dial-in information and webcast registration.

Call Details:

Date:	Thursday, November 9th
Time:	8:30am EDT
Domestic:	1-877-451-6152
International:	1-201-389-0879
Passcode:	13741382
CallMeTM	LINK (active 15 minutes prior to conference call)
Webcast:	https://viavid.webcasts.com/starthere.jsp?ei=1635563&tp_key=28f6dfe71c

About EDAP TMS SA

A recognized leader in the global therapeutic ultrasound market. EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith® i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.com, us.hifu-prostate.com and www.focalone.com.

Company Contact Blandine Confort Investor Relations / Legal Affairs EDAP TMS SA +33 4 72 15 31 50 bconfort@edap-tms.com

Investor Contact John Fraunces LifeSci Advisors, LLC (917) 355-2395 jfraunces@lifesciadvisors.com

 

FAQ

When will EDAP TMS SA release its Q3 2023 financial results?

EDAP TMS SA will release its Q3 2023 financial results on November 9th, 2023.

What is the specialty of EDAP TMS SA?

EDAP TMS SA is the global leader in robotic energy-based therapies.

Who will conduct the conference call and webcast?

The conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, François Dietsch, Chief Financial Officer, and Ken Mobeck, Chief Financial Officer of the U.S. subsidiary.

What are the details of the conference call?

The conference call will be held on November 9th, 2023, at 8:30am EDT. The domestic dial-in number is 1-877-451-6152, and the international dial-in number is 1-201-389-0879. The passcode is 13741382.

Where can I register for the webcast?

You can register for the webcast at https://viavid.webcasts.com/starthere.jsp?ei=1635563&tp_key=28f6dfe71c.